Search - tctmd.com

Displaying 281 - 300 of 349

Sort: Relevancy | Date

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

October 05, 2012

Acute and Long-Term Outcomes of Coronary Stenting in Women vs. Men

Presentation

Acute and Long-Term Outcomes of Coronary Stenting in Women vs. Men

Presenter: Monique Anderson

October 04, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Conference News ESC 2012

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

August 27, 2012

Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial

Presentation ESC 2012

Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial

Presenter: William Wijns

August 27, 2012

News Daily News

Study Suggests Shortening Delay to Noncardiac Surgery After PCI

Yael L. Maxwell

August 17, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

August 16, 2012

News Industry News

Cardionovum® expects to launch next-generation product: drug-eluting coronary stent system, PROLIMUS Biograde

August 08, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

May 18, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

March 26, 2012

News Daily News

Surgery Common, Safe After Coronary Stent Implantation

March 13, 2012

News Daily News

La Cirugía el algo Habitual y Seguro Tras la Implantación de un Stent Coronario

March 13, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

March 06, 2012

News Daily News

Ensayo DESTINY: los SLF son Superiores a los SMD en lesiones por debajo de la rodilla

March 06, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

March 05, 2012

News Industry News

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

February 29, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.